Mahin Alamgir
Dermatology · Keene, NHNPI 1619351897
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 100 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 20.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,541, 5.9 times the $260 reported in 2019.
Across 100 payments — averaging $30.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$623
- Regeneron Healthcare Solutions, Inc.$552
- Amgen$309
- Incyte Corporation$277
- Dermavant Sciences, Inc.$220
- UCB, Inc.$179
- plus $900 from 14 others
Across 4 payments — averaging $707.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$3K
What the payments were for
- Food & beverage$2,98097%
- Education$803%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 27 | $623 |
| Regeneron Healthcare Solutions, Inc. | 12 | $552 |
| Amgen | 4 | $309 |
| Incyte Corporation | 12 | $277 |
| Dermavant Sciences, Inc. | 5 | $220 |
| UCB, Inc. | 4 | $179 |
| Arcutis Biotherapeutics, Inc. | 6 | $173 |
| Organon | 10 | $170 |
| Ferring Pharmaceuticals Inc. | 1 | $104 |
| LEO Pharma Inc. | 5 | $104 |
| Sanofi | 1 | $90 |
| Novartis | 3 | $68 |
| Sun Pharmaceutical Industries Inc. | 2 | $49 |
| E.r. Squibb & Sons, L.L.C. | 2 | $31 |
| Galderma Laboratories, L.p. | 1 | $22 |
| Johnson & Johnson | 1 | $21 |
| Biofrontera Inc. | 1 | $20 |
| Genentech USA, Inc. | 1 | $18 |
| Botanix SB Inc | 1 | $17 |
| Surgenex LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,060 in reported general payments places this provider in the 65th percentile of 75 dermatology providers in New Hampshire.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 15 | $479 |
| Triamcinolone Acetonide | 23 | $239 |
| Hydrocortisone | 25 | $113 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Keene
- Ashley GroupKeene$832
- David HorneKeene$100
- Abel JarellPortsmouth$2.3M
- Robert PosnickNashua$951K
- David PosnickNashua$203K
- Yulianna RussakLebanon$170K
- Peter JenkinManchester$117K
- Neera NathanLondonderry$83K
- Michael LichterNashua$53K
- Michael ChapmanLebanon$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.